🏥 VAERS Vaccine Data Browser

🔒 Privacy & Data Disclaimer

About This Site

This is a public data browser for the Vaccine Adverse Event Reporting System (VAERS). By using this site, you acknowledge and agree to the following:

Data Source & Accuracy

  • Public Data: All data displayed comes from the publicly available VAERS database maintained by the CDC and FDA.
  • No Verification: VAERS accepts all reports without verifying medical accuracy. Reports do not prove causation between vaccines and adverse events.
  • Anyone Can Report: Healthcare providers, patients, family members, and anyone else can submit reports to VAERS.
  • Research Purpose: This data is for transparency, research, and monitoring vaccine safety signals only.

Your Privacy

  • No Personal Data Collection: This site does not collect, store, or track any personal information about visitors.
  • No Cookies: We do not use cookies except for remembering that you've seen this disclaimer (stored locally in your browser).
  • No Analytics: We do not use Google Analytics or any other tracking services.
  • Search Privacy: Your searches and filters are not logged or stored on our servers.
  • Public Data Only: The VAERS data shown here is already public and contains no personally identifiable information.

Medical Disclaimer

  • Not Medical Advice: This tool is for informational purposes only and does not provide medical advice.
  • Consult Healthcare Providers: Always consult qualified healthcare professionals for medical decisions.
  • No Liability: We are not responsible for decisions made based on this data.

Data Interpretation

  • The presence of a report does not mean the vaccine caused the adverse event.
  • Coincidental events are often reported (e.g., a heart attack that happened to occur after vaccination).
  • Serious adverse events must be reported by law, even if unrelated to the vaccine.
  • The database is useful for detecting safety signals that require further investigation.

📖 Help & Search Guide

Column Icons Legend

💀 Death
🏥 Hospitalized
🚑 Emergency Room
♿ Disability
⚠️ Life Threatening

How to Search

💡 Search Tips:
  • Select Year: Choose a specific year OR "All Years" to search across all data
  • All Years requires filters: When searching all years, you must select at least one filter (lot number, vaccine type, outcome, etc.) for performance
  • Lot number tracking: Use "All Years" + Lot Number to track lots across multiple years
  • Combine filters: Use multiple filters together to narrow results (e.g., Age + Vaccine Type + Death)
  • VAERS ID: Search for specific report by ID number
  • Age: Enter exact age (e.g., 25) or decimal (e.g., 0.5 for 6 months)
  • State: Enter 2-letter state code (e.g., CA, NY, TX)
  • Vaccine Type: Search partial names (e.g., "COVID19", "FLU", "HPV")
  • Manufacturer: Search by company (e.g., "PFIZER", "MODERNA")
  • Lot Number: Search specific vaccine lot (works great with "All Years")
  • Symptoms: Search for any symptom keyword (e.g., "fever", "rash")
  • Death/Hospitalized: Filter to only show cases with these outcomes

Understanding the Data

  • Reports are unverified: VAERS accepts all reports without medical verification
  • Not proof of causation: A report does not mean the vaccine caused the event
  • Anyone can report: Healthcare providers, patients, and family members can submit reports
  • Multiple vaccines: One report may list multiple vaccines given at the same time
  • Blank fields: Not all fields are required, so some data may be missing

Using the Table

  • Sort columns: Click column headers (ID, Age, Sex, Date, Died) to sort
  • Expand text: Click "More" to see full narrative or symptom text
  • Navigate pages: Use pagination controls at top and bottom of table
  • Export results: Click "📥 Export CSV" to download filtered data (max 10,000 records)

💡 Frequently Asked Questions (FAQ)

What is this site?

🏥 VAERS Vaccine Data Browser is an independent, third-party data browser for publicly available VAERS (Vaccine Adverse Event Reporting System) data.

Important: This site is NOT affiliated with, endorsed by, or operated by the CDC, FDA, or any government agency. We are an independent service that makes public VAERS data easier to search and analyze.

What is VAERS?

VAERS (Vaccine Adverse Event Reporting System) is a national early warning system established in 1990 to detect possible safety problems with vaccines. It's co-managed by the CDC (Centers for Disease Control and Prevention) and FDA (Food and Drug Administration).

VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination.

Official VAERS website: vaers.hhs.gov

Is this data HIPAA compliant?

Yes, absolutely. All VAERS data displayed here is:

  • Publicly available - Published by the CDC/FDA on their official website
  • De-identified - Contains no personally identifiable information (names, addresses, contact info removed)
  • Legally accessible - Available to researchers, media, and the general public under FOIA (Freedom of Information Act)
  • Not protected health information - Once de-identified and published by the government, it's no longer covered by HIPAA restrictions

This site displays the same public data available at vaers.hhs.gov/data.

Why does this site exist?

We believe in transparency and public access to health data. While the CDC/FDA provide VAERS data, their official site:

  • Is difficult to search and filter
  • Requires downloading large CSV files and technical knowledge
  • Is not user-friendly for the average person

This independent site makes the same publicly available data easier to search, filter, and understand for researchers, journalists, healthcare workers, and concerned citizens.

Where does the data come from?

All data is downloaded directly from the official CDC/FDA VAERS website at vaers.hhs.gov/data.

The data is:

  • Publicly released by the CDC/FDA every week
  • Available as downloadable CSV files
  • Imported into this site's database for easier searching
  • Displayed exactly as provided (no modifications or filtering)

This site does not collect, modify, or add to the official VAERS data.

My vaccine lot number matches one with deaths/serious events - should I be worried?

Important context:

  • VAERS reports do NOT prove causation - A report means an event occurred after vaccination, but doesn't mean the vaccine caused it
  • Anyone can report - Reports are not verified for medical accuracy before being published
  • Coincidences happen - When millions of people get vaccinated, some will experience unrelated medical events afterward
  • Large lot numbers - Popular vaccines may have hundreds of thousands of doses from one lot number
  • More vaccinations = more reports - Lots used widely will naturally have more reports

What to do:

  • Don't panic - VAERS data requires expert analysis to interpret
  • Talk to your doctor if you have concerns
  • Check official CDC/FDA safety communications for genuine safety signals
  • Remember: billions of vaccine doses have been safely administered

Can I trust VAERS data?

VAERS is valuable but has limitations:

Strengths:

  • ✅ Early warning system for potential safety signals
  • ✅ Open and transparent - publicly accessible
  • ✅ Accepts all reports regardless of likelihood of causation
  • ✅ Monitored by CDC/FDA experts who investigate concerning patterns

Limitations:

  • ⚠️ Reports are unverified - not investigated before publication
  • ⚠️ Cannot determine if vaccine caused the event
  • ⚠️ Underreporting - not all adverse events are reported
  • ⚠️ Overreporting - coincidental events may be reported
  • ⚠️ Incomplete data - not all fields are required

Bottom line: VAERS is an important tool for safety monitoring, but individual reports should not be used as proof that a vaccine caused harm.

What are "adverse events"?

An adverse event is any undesirable health occurrence that happens after vaccination, including:

  • Common reactions: Sore arm, mild fever, fatigue (usually expected)
  • Serious events: Hospitalization, disability, life-threatening illness, death
  • Coincidental events: Medical conditions that would have occurred anyway

Important: An adverse event doesn't mean the vaccine caused it - only that it occurred after vaccination. Many reported events are coincidental or unrelated.

Why are some lot numbers listed multiple times?

This is normal and expected! A person may receive multiple doses of the same vaccine from the same lot number:

  • COVID vaccines require 2-3 doses
  • HPV, Hepatitis B, and other vaccines have multi-dose schedules
  • Each dose is recorded as a separate entry

Example: Person receives Pfizer COVID dose 1 (lot ABC123) and dose 2 (lot ABC123) - lot ABC123 appears twice in their report.

How often is this data updated?

The CDC/FDA releases new VAERS data every Friday. This site is typically updated:

  • Weekly or bi-weekly for recent data
  • Check the available years to see what data is currently loaded
  • During updates, the site may be in maintenance mode temporarily

Where can I learn more?

⚠️ DISCLAIMER: This data is from the Vaccine Adverse Event Reporting System (VAERS). Reports do not establish causation between vaccines and adverse events. Anyone can submit a report, and reports are not verified. This is raw data for transparency and research purposes only.
34,052
Total Reports (2025)
500
Deaths Reported
1,634
Hospitalizations
30
ER Visits
1,191
Disabilities
570
Life Threatening
🔄 Reset 📥 Export CSV
ID Age Sex State Date ▼ Onset Days Vaccine Manufacturer Lot # Symptoms Narrative 💀 🏥 🚑 ♿ ⚠️
2866132 73 F NY 10/15/2025 FLU3
 SANOFI PASTEUR
 U8881CA
Incorrect dose administered, No adverse event Incorrect dose administered, No adverse event
patient was inadvertently administered the Fluzone prefilled syringe, , intramuscularly into the lef... patient was inadvertently administered the Fluzone prefilled syringe, , intramuscularly into the left deltoid, rather than the intended Fluzone High-Dose with no reported adverse event; Initial information received on 09-Oct-2025 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 73 years old female patient who was inadvertently administered the Influenza USP Trival A-B Subvirion No Preservative Vaccine [Fluzone], intramuscularly into the left deltoid, rather than the intended Influenza Usp Trival A-B High Dose Subvirion Vaccine [Fluzone High Dose] with no reported adverse event while receiving vaccines and. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 08-Oct-2025, the patient received 0.5mL dose of suspect Influenza USP Trival A-B Subvirion No Preservative Vaccine, once, Suspension for injection in pre-filled syringe (unknown strength), lot U8881CA and expiry date 30-Jun-2026 via intramuscular route in the left deltoid for immunisation rather than the intended Influenza Usp Trival A-B High Dose Subvirion Vaccine, Suspension for injection in pre-filled syringe (unknown strength and expiry date) lot number not reported via unknown route in unknown administration site for prophylactic vaccination (immunisation), with no reported adverse event (wrong product administered) (latency Same day). Reportedly, The patient received no concomitant vaccines. This error was the result of an order error, and not the result of confusing the two products. Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. More
2866133 54 M PA 10/15/2025 FLU3
UNK
 SANOFI PASTEUR
UNKNOWN MANUFACTURER
 U8767AA
No adverse event, Wrong product administered; No adverse event, Wrong product ad... No adverse event, Wrong product administered; No adverse event, Wrong product administered More
administration of fluzone np to a patient who was intended by the facility to receive flublok with n... administration of fluzone np to a patient who was intended by the facility to receive flublok with no reported adverse event; Initial information along with live follow up received on 10-Oct-2025 both of which are processed together regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 54 years old male patient had administration of influenza USP trival A-B subvirion no preservative vaccine [Fluzone] who was intended by the facility to receive influenza trivalent recombinant vaccine [Flublok TIV] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 23-Sep-2025 the patient had administration of 0.5 ml (dose 1) once of suspect influenza USP trival A-B subvirion no preservative vaccine (Suspension for injection) (lot: U8767AA; expiry date: 30-Jun-2026; strength: standard) via intramuscular route in the left deltoid for Immunization who was intended by the facility to receive influenza trivalent recombinant vaccine (Solution for Injection) with no reported adverse event (wrong product administered) (latency: same day). It was reported, "the patient has not reported any allergy to eggs." Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. More
2866134 F DC 10/15/2025 FLU3
 SANOFI PASTEUR
Product administered at inappropriate site Product administered at inappropriate site
pre-assessed as an off-label use as per local labelling due to use of unapproved alternative injecti... pre-assessed as an off-label use as per local labelling due to use of unapproved alternative injection site patient may have received possibly fluzone hd in the gluteal area before with no reported ae; Initial information received on 10-Oct-2025 regarding an unsolicited valid non-serious case received from a nurse. This case involves an unknown age female patient who had use of unapproved alternative injection site patient may have received possibly influenza Usp Trival A-B High Dose Subvirion Vaccine [Fluzone High Dose] in the gluteal area before with no reported ae (adverse event) which was pre-assessed as an off-label use as per local labelling. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. At the time of the event, the patient had ongoing Poliomyelitis. Concomitant medications included COVID-19 vaccine for Immunisation. On an unknown date, the patient received a dose of suspect influenza Usp Trival A-B High Dose Subvirion Vaccine Suspension for injection in pre-filled syringe (lot number, dose, strength and expiry not reported) via unknown route in gluteal muscle as Immunization that had use of unapproved alternative injection site with no reported ae (adverse event) which was pre-assessed as an off-label use as per local labelling (off label use) (latency: same day). There will be no information on batch number and expiration date corresponding to the one at time of event occurrence. It was reported "A nurse is asking for guidance on administering FLUZONE HD in an alternate site to a senior resident that has Polio Syndrome, which has diminished usable tissue in the deltoid. She has been told that historically, the patient has gotten COVID and flu vaccines in the gluteal muscle instead, and they are supposed to administer FLUZONE HD next week. She is asking if they can give that injection in the gluteal muscle, and she is aware there may be an effect on a nerve. Caller mentioned that she believes the patient may have received (unspecified) COVID vaccine and possibly FLUZONE HD in the gluteal area before. There is no further information available, as she states it was in the past and at a different facility." Action taken: not applicable. More
2866135 MO 10/15/2025 FLU3
 SANOFI PASTEUR
Incorrect dose administered Incorrect dose administered
45yr old patient received FLUZONE HD with no reported adverse event; Initial information received on... 45yr old patient received FLUZONE HD with no reported adverse event; Initial information received on 10-Oct-2025 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 45 years old and unknown gender patient who received influenza USP TRIVAL A-B high dose subvirion vaccine [Fluzone HD] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received an unknown dose of influenza USP TRIVAL A-B high dose subvirion vaccine Suspension for injection in pre-filled syringe (strength, expiry date and lot number not reported) via unknown route in unknown administration site for Influenza (Influenza immunisation) with no reported adverse event (product administered to patient of inappropriate age) (same day latency). Information on the batch number was requested corresponding to the one at time of event occurrence. Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. More
2866136 M CT 10/15/2025 FLU3
 SANOFI PASTEUR
 U8440AA
Expired product administered, No adverse event Expired product administered, No adverse event
administration of expired dose with no reported adverse event; Initial information received on 13-Oc... administration of expired dose with no reported adverse event; Initial information received on 13-Oct-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves an unknown age male patient who had administration of expired dose with no reported adverse event of influenza trivalent recombinant vaccine [Flublok]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 13-Oct-2025, the patient received expired 0.5 ml dose of suspect influenza trivalent recombinant vaccine (lot U8440AA, Expiry date: 30-Apr-2025, strength: standard) via intramuscular route in the arm for influenza (expired dose with no reported adverse event (expired product administered; latency: same day) Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. More
2866137 F CT 10/15/2025 UNK
 UNKNOWN MANUFACTURER
 U8440AA
Expired product administered, No adverse event Expired product administered, No adverse event
patient received expired dose with no reported adverse event; Initial information received on 13-Oct... patient received expired dose with no reported adverse event; Initial information received on 13-Oct-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves an unknown age female patient who received expired dose of influenza trivalent recombinant vaccine [flublok TIV] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 13-Oct-2025, the patient received 0.5 ml of suspect influenza trivalent recombinant vaccine Solution for injection of standard strength, frequency once with lot U8440AA and expiry date 30-APR-2025 via intramuscular route in the arm NOS (Not otherwise specified) with no reported adverse event (Expired product administered) (Latency same day). Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. More
2866146 F MN 10/15/2025 VARZOS
VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
 UNK
UNK
Herpes zoster, Incomplete course of vaccination; Herpes zoster, Incomplete cours... Herpes zoster, Incomplete course of vaccination; Herpes zoster, Incomplete course of vaccination More
never received the second dose; The patient developed Shingles; This non-serious case was reported b... never received the second dose; The patient developed Shingles; This non-serious case was reported by a consumer via call center representative and described the occurrence of shingles in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix and did not receive 2nd dose of Shingrix. In AUG-2025, more than 2 years after receiving Shingrix, the patient experienced shingles (Verbatim: The patient developed Shingles ). The patient experienced incomplete course of vaccination (Verbatim: never received the second dose). The outcome of the shingles was unknown and the outcome of the incomplete course of vaccination was not applicable. It was unknown if the reporter considered the shingles to be related to Shingrix. It was unknown if the company considered the shingles to be related to Shingrix. Additional Information: GSK Receipt Date: 03-OCT-2025 The patient received the first dose of Shingrix in 2018 and never received the second dose. The patient developed Shingles in the beginning of AUG 2025. The batch number was not provided, and we are unable to contact the reporter. More
2866147 MN 10/15/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Incomplete course of vaccination Incomplete course of vaccination
Missed dose; This non-serious case was reported by a consumer via call center representative and des... Missed dose; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 86-year-old patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose in 2019). The patient did not receive the 2nd dose of Shingrix. The patient experienced incomplete course of vaccination (Verbatim: Missed dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date:10-OCT-2025 The reporter was the patient who received her first dose of Shingrix in 2019 and did not go back for the second dose. More
2866148 F 10/15/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Inappropriate schedule of product administration Inappropriate schedule of product administration
Drug dose administered interval to long; This non-serious case was reported by a consumer via call c... Drug dose administered interval to long; This non-serious case was reported by a consumer via call center representative and described the occurrence of drug dose administration interval too long in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose in 2020). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: Drug dose administered interval to long). The outcome of the drug dose administration interval too long was not applicable. Additional Information: GSK Receipt Date:10-OCT-2025 The patient received the first dose of Shingrix in 2020 and the second dose on 2025. More
2866149 10/15/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Pain in extremity Pain in extremity
sore arm; This non-serious case was reported by a consumer via interactive digital media and describ... sore arm; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced pain in arm (Verbatim: sore arm). The outcome of the pain in arm was resolved. The reporter considered the pain in arm to be related to Shingrix. The company considered the pain in arm to be related to Shingrix. Additional Information: GSK Receipt Date: 05-OCT-2025 This case was reported by a patient via interactive digital media. Patient received fifth booster dose. Patient believed that having sore arm this time was due to Shingrix. Patient never tested positive for Covid and never had shingles painful lesions. The batch number was not provided and unable to contact the reporter. More
2866151 M 10/15/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 UNK
Extra dose administered Extra dose administered
received 3rd dose of Shingrix; This non-serious case was reported by a pharmacist via interactive di... received 3rd dose of Shingrix; This non-serious case was reported by a pharmacist via interactive digital media and described the occurrence of extra dose administered in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 3rd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: received 3rd dose of Shingrix). The outcome of the extra dose administered was not applicable. Additional Information: GSK Receipt Date:09-OCT-2025 This case was reported by a consumer via interactive digital media. The patient received late 2nd dose of Shingrix. Patient received a third dose of Shingrix and it was considered a non-serious case. More
2866154 F NE 10/15/2025 DTAP
 GLAXOSMITHKLINE BIOLOGICALS
 9PT2F
Product administered to patient of inappropriate age Product administered to patient of inappropriate age
(Infanrix) to a 46 year old patient; This non-serious case was reported by a other health profession... (Infanrix) to a 46 year old patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 46-year-old female patient who received DTPa (Infanrix) (batch number 9PT2F, expiry date 10-MAR-2026) for prophylaxis. On 01-OCT-2025, the patient received Infanrix. On 01-OCT-2025, an unknown time after receiving Infanrix, the patient experienced inappropriate age at vaccine administration (Verbatim: (Infanrix) to a 46 year old patient). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 02-OCT-2025 Medical assistant ended up giving a vaccines for children shot for children (Infanrix) to a 46 year old patient on 01 Oct 2025. More
2866155 NJ 10/15/2025 MENB
MENB
MENB
 NOVARTIS VACCINES AND DIAGNOSTICS
NOVARTIS VACCINES AND DIAGNOSTICS
NOVARTIS VACCINES AND DIAGNOSTICS


Inappropriate schedule of product administration; Inappropriate schedule of prod... Inappropriate schedule of product administration; Inappropriate schedule of product administration; Inappropriate schedule of product administration More
received 1st and 2nd dose at 8 and 9 years of age; Bexsero late third dose; This non-serious case wa... received 1st and 2nd dose at 8 and 9 years of age; Bexsero late third dose; This non-serious case was reported by a physician via call center representative and described the occurrence of drug dose administration interval too long in a 16-year-old patient who received Men B NVS (Bexsero) for prophylaxis. Co-suspect products included Men B NVS (Bexsero) for prophylaxis and Men B NVS (Bexsero) for prophylaxis. On 02-OCT-2025, the patient received the 3rd dose of Bexsero. On an unknown date, the patient received the 2nd dose of Bexsero and the 1st dose of Bexsero. On 02-OCT-2025, an unknown time after receiving Bexsero and not applicable after receiving Bexsero and Bexsero, the patient experienced drug dose administration interval too long (Verbatim: Bexsero late third dose). On an unknown date, the patient experienced inappropriate age at vaccine administration (Verbatim: received 1st and 2nd dose at 8 and 9 years of age). The outcome of the drug dose administration interval too long and inappropriate age at vaccine administration were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 04-OCT-2025 The physician reported that the Patient received 1 dose of Bexsero at age 8, 1 dose at age 9 and, 1 dose at age 16. The reporter was ask should patient receive another dose of Bexsero. More
2866156 10/15/2025 COVID19
FLUX
 MODERNA
UNKNOWN MANUFACTURER

Fatigue, Headache, Pain in extremity; Fatigue, Headache, Pain in extremity Fatigue, Headache, Pain in extremity; Fatigue, Headache, Pain in extremity
left arm is experiencing significant soreness; fatigue; Light headache; This spontaneous case was re... left arm is experiencing significant soreness; fatigue; Light headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (left arm is experiencing significant soreness), FATIGUE (fatigue) and HEADACHE (Light headache) in a patient of an unknown age and gender who received mRNA-1273.251 (Spikevax LP.8.1 PFS) for COVID-19 prophylaxis. Co-suspect product included non-company product Influenza vaccine (Flu) for an unknown indication. No Medical History information was reported. On 09-Oct-2025 at 5:00 AM, the patient received dose of mRNA-1273.251 (Spikevax LP.8.1 PFS) (unknown route) 1 dosage form. On 09-Oct-2025 at 5:00 PM, the patient received dose of Influenza vaccine (Flu) (unknown route) 1 dosage form. In October 2025, the patient experienced PAIN IN EXTREMITY (left arm is experiencing significant soreness), FATIGUE (fatigue) and HEADACHE (Light headache). At the time of the report, PAIN IN EXTREMITY (left arm is experiencing significant soreness), FATIGUE (fatigue) and HEADACHE (Light headache) outcome was unknown. No concomitant medication was reported. Patent received Spikevax dose yesterday at 5 pm. Patient took it alongside the flu vaccine. patient left arm was experiencing significant soreness. Patient was also experiencing fatigue and a light headache. No treatment information was reported. More
2866157 66 F 10/15/2025 COVID19
 PFIZER\BIONTECH
Back pain, Vaccination site nodule Back pain, Vaccination site nodule
Local knot at site of injection 2-3 days post vaccine; Muscle pain around back that began after vacc... Local knot at site of injection 2-3 days post vaccine; Muscle pain around back that began after vaccination and continues; This is a spontaneous report received from a Pharmacist from a sales representative. A 66-year-old female patient (not pregnant) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), on 25Sep2025 as dose number unknown, single (Batch/Lot number: unknown) at the age of 66 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing). Concomitant medication(s) included: TIRZEPATIDE. Past drug history included: Morphine, reaction(s): "Morphine: Allergy". The following information was reported: VACCINATION SITE NODULE (non-serious) with onset 26Sep2025, outcome "recovered", described as "Local knot at site of injection 2-3 days post vaccine"; BACK PAIN (non-serious) with onset 26Sep2025, outcome "not recovered", described as "Muscle pain around back that began after vaccination and continues". Therapeutic measures were not taken as a result of vaccination site nodule, back pain. Additional information: Did the patient receive any other vaccines on the same date as the vaccine(s) for which you are reporting?: No. Did the patient receive any other vaccines within 4 weeks PRIOR to the vaccine(s) for which you are reporting?: No. Were you/Was the patient taking any other medications within 2 weeks of the event starting?: Yes. The reported Event: Local knot at site of injection 2-3 days post vaccine (resolved); muscle pain around back that began after vaccination and continued. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained. More
2866158 M 10/15/2025 RSV
 PFIZER\WYETH
Arthralgia, Pain in extremity Arthralgia, Pain in extremity
Knee pain that is killing him/knees are killing me, my knees and down my legs/Joint pain; This is a ... Knee pain that is killing him/knees are killing me, my knees and down my legs/Joint pain; This is a spontaneous report received from a Consumer or other non HCP from medical information team. A male patient received rsv vaccine prot.subunit pref 2v (ABRYSVO), on 10Oct2025 as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ARTHRALGIA (non-serious) with onset 11Oct2025, outcome "unknown", described as "Knee pain that is killing him/knees are killing me, my knees and down my legs/Joint pain". Additional information: caller experienced some knee pain that is killing him. It appeared after getting the RSV shot, so he'd like to know if it may be related to this vaccine. He received the RSV vaccine on Friday, and it seemed fine at first. Then, the pain appeared and it's killing him. He read the PI the pharmacist gave him, and he found that it may cause joint pain. The patient had a question, that he got that RSV shot that Pfizer makes, he got that on Friday. Saturday morning he went to get up and his knees are killing him, his knees and down his legs and he looked up some of the side effects and it says could cause joint pain. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained. More
2866159 M NY 10/15/2025 PNC20
 PFIZER\WYETH
 LN4928
Injection site cellulitis, Injection site erythema, Injection site pain, Injecti... Injection site cellulitis, Injection site erythema, Injection site pain, Injection site rash More
Erythema to the injection site; Cellulitis at the injection site; Tenderness; Itching; Rash; This is... Erythema to the injection site; Cellulitis at the injection site; Tenderness; Itching; Rash; This is a spontaneous report received from a Consumer or other non HCP. An 87-year-old male patient received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), as dose number unknown, single (Lot number: LN4928) for immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: VACCINATION SITE ERYTHEMA (non-serious), outcome "unknown", described as "Erythema to the injection site"; VACCINATION SITE CELLULITIS (non-serious), outcome "unknown", described as "Cellulitis at the injection site"; TENDERNESS (non-serious), outcome "unknown"; PRURITUS (non-serious), outcome "unknown", described as "Itching"; RASH (non-serious), outcome "unknown". Additional information: an 87 years old patient that has a ton of medication so that's all irrelevant reactions. When probed for the Lab test and event details, reporter stated: I am just going to think it came, it happened like couple of days after the vaccine so, within 3 to 4 days, they had a reaction all 3.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202500202794 same reporter/drug/event, different patient;US-PFIZER INC-202500202833 same reporter/drug/event, difference patient; More
2866160 F 10/15/2025 COVID19
 PFIZER\BIONTECH
Vaccination site erythema, Vaccination site pruritus Vaccination site erythema, Vaccination site pruritus
mild Itching and redness at the covtd shot Injection site/similar reactions with previous covid vacc... mild Itching and redness at the covtd shot Injection site/similar reactions with previous covid vaccines; mild Itching and redness at the covtd shot Injection site/similar reactions with previous covid vaccines; This is a spontaneous report received from a Consumer or other non HCP from License Party. Other Case identifier(s): AE-021146 (BioNTech), 2025SA138951 (SANOFI). A 74-year-old female patient (not pregnant) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PRURITUS (non-serious), VACCINATION SITE ERYTHEMA (non-serious), outcome "unknown" and all described as "mild Itching and redness at the covtd shot Injection site/similar reactions with previous covid vaccines". Batch/lot number is not provided, and it cannot be obtained. More
2866161 10/15/2025 COVID19
 PFIZER\BIONTECH
Musculoskeletal stiffness Musculoskeletal stiffness
The patient neck felt stiff and tight to turn it; This is a spontaneous report received from a Consu... The patient neck felt stiff and tight to turn it; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A patient (age and gender not provided) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MUSCULOSKELETAL STIFFNESS (non-serious), outcome "unknown", described as "The patient neck felt stiff and tight to turn it". Additional information: It was reported chat question verbatim1: Could covid vaccine have caused osteoarthritis? The information on the batch/lot number for BNT162b2 omicron (lp.8.1) will be requested and submitted if and when received. More
2866162 51 F PA 10/15/2025 COVID19
COVID19
FLUX
FLUX
 PFIZER\BIONTECH
PFIZER\BIONTECH
UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER



Body temperature increased, Chills, Fatigue, Heart rate increased, Nausea; Pain;... Body temperature increased, Chills, Fatigue, Heart rate increased, Nausea; Pain; Body temperature increased, Chills, Fatigue, Heart rate increased, Nausea; Pain More
Addition of nausea the next morning; Within 8 hours chills, body aches and fatigue; Within 8 hours c... Addition of nausea the next morning; Within 8 hours chills, body aches and fatigue; Within 8 hours chills, body aches and fatigue; Within 8 hours chills, body aches and fatigue; Elevated heart rate and temp at night; Elevated heart rate and temp at night; This is a spontaneous report received from a Consumer or other non HCP. A 51-year-old female patient (not pregnant) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), on 13Oct2025 at 10:00 as dose 1, single (Batch/Lot number: unknown) at the age of 51 years, in left arm for covid-19 immunisation; influenza vaccine (INFLUENZA VACCINE), on 13Oct2025 as dose number unknown, single, in left arm for immunisation. The patient's relevant medical history included: "Ulcerative colitis" (unspecified if ongoing); "anal cancer" (unspecified if ongoing); "penicillin allergy" (unspecified if ongoing). Concomitant medication(s) included: ESTROGEN topical; PROGESTERONE; ESTRADIOL. The following information was reported: HEART RATE INCREASED (non-serious), BODY TEMPERATURE INCREASED (non-serious) all with onset 13Oct2025 at 18:00, outcome "not recovered" and all described as "Elevated heart rate and temp at night"; CHILLS (non-serious), PAIN (non-serious), FATIGUE (non-serious) all with onset 13Oct2025 at 18:00, outcome "not recovered" and all described as "Within 8 hours chills, body aches and fatigue"; NAUSEA (non-serious) with onset 14Oct2025, outcome "not recovered", described as "Addition of nausea the next morning". Therapeutic measures were taken as a result of chills, pain, fatigue, heart rate increased, body temperature increased, nausea. Additional information: The patient received Advil as treatment for the events. The information on the batch/lot number for BNT162b2 omicron (lp.8.1) will be requested and submitted if and when received. More
2866163 10/15/2025 COVID19
 PFIZER\BIONTECH
Eructation Eructation
burping; This is a spontaneous report received from a Consumer or other non HCP. A patient (age and... burping; This is a spontaneous report received from a Consumer or other non HCP. A patient (age and gender not provided) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), on 13Oct2025 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, single; unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (Dose 2, single; unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (Dose 3, single; unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (Dose 4, single; unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (Dose 5, single; unknown manufacturer), for COVID-19 immunization. The following information was reported: ERUCTATION (non-serious) with onset 13Oct2025, outcome "unknown", described as "burping". Additional information: the patient took a shot yesterday (13Oct2025) and last night started burping. Patient was burping today and it's unusual because patient have never had that before. Patient have had shots previously about five times they think and never had burping problem. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained. More
2866164 72 F MD 10/15/2025 COVID19
 PFIZER\BIONTECH
 LM2210
Headache, Tinnitus Headache, Tinnitus
had a slight headache every time; tinnitus/it gets worse every time I get a covid vaccine; This is a... had a slight headache every time; tinnitus/it gets worse every time I get a covid vaccine; This is a spontaneous report received from a Consumer or other non HCP. An elderly female patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), on 16Oct2024 as dose 1, 0.3 ml, single (Lot number: LM2210) at the age of 72 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, 0.3 mL, SINGLE, Lot number: FG3527, Intramuscular in the right arm), administration date: 08Nov2021, when the patient was 69-year-old, for COVID-19 Immunization, reaction(s): "Headache", "Tinnitus"; BNT162b2 (DOSE 2, 0.3 mL, SINGLE, Lot number: GJ3277, Intramuscular in the right arm), administration date: 12Oct2022, when the patient was 70-year-old, for COVID-19 Immunization, reaction(s): "Headache", "tinnitus/it gets worse every time I get a covid vaccine"; BNT162b2 (DOSE 3 (BOOSTER), 0.3 mL, SINGLE, Lot number: HG2282, Intramuscular in the left arm), administration date: 09Oct2023, when the patient was 71-year-old, for COVID-19 Immunization, reaction(s): "Headache", "tinnitus/it gets worse every time I get a covid vaccine"; BNT162b2 (DOSE 4 (BOOSTER), 0.3 mL, SINGLE, Lot number: HN0477, Intramuscular in the right arm), administration date: 24Apr2024, when the patient was 72-year-old, for COVID-19 Immunization, reaction(s): "Headache", "tinnitus/it gets worse every time I get a covid vaccine". The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "had a slight headache every time"; TINNITUS (non-serious), outcome "unknown", described as "tinnitus/it gets worse every time I get a covid vaccine". Additional information: The patient experienced headache which has been her reaction to previous COVID-19 vaccines. She has a slight headache every time. Also, she experienced tinnitus and it got worse every time she gets a COVID vaccine.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202500192477 same patient/suspect vaccine; different dose; similar events; More
2866165 10/15/2025 COVID19
 PFIZER\BIONTECH
Vaccination site pain Vaccination site pain
tenderness at injection site; This is a spontaneous report received from a Consumer or other non HCP... tenderness at injection site; This is a spontaneous report received from a Consumer or other non HCP. Other Case identifier(s): MOD-2025-789963 (Moderna). A patient (age and gender not provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "recovered", described as "tenderness at injection site". Additional information: Consumer describes the occurrence of VACCINATION SITE PAIN (tenderness at injection site) in a patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. Co-suspect product included non-company product Pfizer BioNTech COVID-19 vaccine for an unknown indication. No Medical History information was reported. No concomitant medications were reported. The patient had COVID vaccinations since they first started coming out, and probably the patient had the most recent one or something within the past year (1 year and a half or something like that). The patient had received last dose last year (2024) or two years ago (2023). The patient did not have any reactions to any of the vaccinations of any kind, particularly in relation to flu vaccines and the COVID vaccines that the patient been getting fairly frequently. Patient had tenderness at the injection site in some cases and for few times, the patient did not have any reaction. Treatment medication was not reported. Batch/lot number is not provided, and it cannot be obtained. More
2866166 F 10/15/2025 COVID19
FLUX
VARZOS
 PFIZER\BIONTECH
UNKNOWN MANUFACTURER
GLAXOSMITHKLINE BIOLOGICALS


Headache, Pain; Headache, Pain; Headache, Pain Headache, Pain; Headache, Pain; Headache, Pain
headaches and body aches; headaches and body aches; This is a spontaneous report received from a Con... headaches and body aches; headaches and body aches; This is a spontaneous report received from a Consumer or other non HCP and an Other HCP. Other Case identifier(s): 2025SA281951 (Sanofi). A 65-year-old female patient received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation; dupilumab (DUPIXENT), since 08Sep2025 at 600 mg (600 mg ( 1x)), subcutaneous for dermatitis atopic; influenza vaccine (INFLUENZA VACCINE), as dose number unknown, single for immunisation; varicella zoster vaccine rge (cho) (SHINGRIX), as dose number unknown, single for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), PAIN (non-serious) all with onset 16Sep2025, outcome "not recovered" and all described as "headaches and body aches". The action taken for dupilumab was unknown. Additional information: On 16Sep2025 the patient developed a non-serious event "headaches and body aches" (pain) (headache) (latency: 8 days following the first dose intake of DUPILUMAB, (unknown latency Covid-19 Vaccine, Influenza Vaccine and Shingles Vaccine. (unknown batch number and expiry date for all events). Information regarding batch number and expiration date corresponding to the one at time of event occurrence was requested. It was reported "patient reports headaches and body aches since 16Sep2025 after receiving shingles, influenza, and covid-19 vaccines, ongoing, unknown if md (medical doctor) is aware." It was not reported if the patient received a corrective treatment for both the events. At time of reporting, the outcome was Not Recovered / Not Resolved for both the events. Company causality for drug DUPIXENT and events reported as related. The information on the batch/lot number for BNT162b2 omicron (lp.8.1) will be requested and submitted if and when received. More
2866167 10/15/2025 COVID19
 PFIZER\BIONTECH
Asthenia, Chills, Headache, Pain, Pyrexia Asthenia, Chills, Headache, Pain, Pyrexia
headache; chills; fever/night fever; body aches; weak; This is a spontaneous report received from a ... headache; chills; fever/night fever; body aches; weak; This is a spontaneous report received from a Consumer or other non HCP. Other Case identifier(s): MOD-2025-789973 (Moderna), AE-00230870 (Moderna), AE-00230887 (Moderna). A patient (age and gender not provided) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), in Nov2024 as dose 1, single (Batch/Lot number: unknown) intramuscular for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious) with onset Nov2024, outcome "recovered", described as "body aches"; PYREXIA (non-serious) with onset Nov2024, outcome "recovered", described as "fever/night fever"; HEADACHE (non-serious), outcome "unknown"; CHILLS (non-serious), outcome "unknown"; ASTHENIA (non-serious), outcome "unknown", described as "weak". Additional information: Day of suspect product administration and onset date of both events (Nov2024). caller informed that had side effects from previous Pfizer OVID-19 vaccine that took last Nov2024. Caller stated that had fever and body aches on the day of vaccination. Batch/lot number is not provided, and it cannot be obtained. More
2866169 69 F MD 10/15/2025 COVID19
 PFIZER\BIONTECH
Headache, Tinnitus Headache, Tinnitus
headache; tinnitus; This is a spontaneous report received from a Consumer or other non HCP. A 73-ye... headache; tinnitus; This is a spontaneous report received from a Consumer or other non HCP. A 73-year-old female patient received BNT162b2 (BNT162B2), on 06Apr2021 as dose 1, single (Batch/Lot number: unknown) at the age of 69 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), outcome "unknown"; TINNITUS (non-serious), outcome "unknown". Additional information: The patient had her first covid shot on 06Apr2021 and had a slight headache every time. Also, the patient had tinnitus, and it gets worse every time she gets a covid vaccine. More
2866171 74 M TX 10/15/2025 UNK
 UNKNOWN MANUFACTURER
 407268
Needle issue, Underdose Needle issue, Underdose
Did not receive all the dosage, he received only about half the dosage; During the vaccination the p... Did not receive all the dosage, he received only about half the dosage; During the vaccination the product leaked from the needle; This spontaneous case, initially received on 03-Oct-2025, was reported by a health professional and concerns an elderly male patient. Concomitant medications and medical history were unknown. Administration of company suspect drug: On 03-Oct-2025, the patient received Fluad (TIV) for Immunization for the prevention of influenza disease, Dose regimen: Not reported, Route of Administration: Not Reported, Anatomical location: Not Reported, Lot number: 407268. No additional suspect drugs. Adverse reactions/events and outcomes: On 03-Oct-2025, same day of vaccination, the patient Did not receive all the dosage, he received only about half the dosage (outcome: Unknown, stop date: 03-Oct-2025), During the vaccination the product leaked from the needle (outcome: Unknown, stop date: 03-Oct-2025). The pharmacist tried to vaccinate patient with Fluad at the time of vaccination the product leaked from the needle and the patient did not receive all the dosage, he received only about half the dosage. Pharmacist reported this could happen because or needle was not well attached or it was defective. How many defective units? 1 Was the dose administered? Yes, partially Is the complaint sample available? unknown The defect was noticed during the administration. It was unknown if the plunger was depressed/not depressed. It was unknown if the needle shield was in place. The location of the leak was unknown. It was unknown if there were any signs of damage on the syringe and on the needle. The needle used was the pre-filled syringe (PFS) manufacturer. It was unknown if the needle appeared tightly attached. Fluad (TIV) action taken: Not Applicable Reporter's assessment: The primary reporter (pharmacist) did not provide a seriousness or causality assessment for events Did not receive all the dosage, he received only about half the dosage, During the vaccination the product leaked from the needle.; Reporter's Comments: Events Did not receive all the dosage, he received only about half the dosage, During the vaccination the product leaked from the needle assessed not related due to events nature (special situation). More
2866172 70 M CO 10/15/2025 SMALLMNK
SMALLMNK
 BAVARIAN NORDIC
BAVARIAN NORDIC
 96868
96868
Arteriogram carotid, Computerised tomogram head, Condition aggravated, Diplopia,... Arteriogram carotid, Computerised tomogram head, Condition aggravated, Diplopia, Magnetic resonance imaging head; Speech disorder, Urine analysis More
Increased speech deficit, R eye dipolopia. ER visit 10/10/25 and 10/11/25 with admission until 10/12... Increased speech deficit, R eye dipolopia. ER visit 10/10/25 and 10/11/25 with admission until 10/12/25. Described at that time 3-4 day history of symptoms. Underwent CT head, CT angio head and neck, MRI brain, u/a. Neurology consultation (felt could be psychogenic but noted no new life stressors) vs recrudescence of prior stroke. Improvement by 10/12/25. More
✓
2866173 57 M MD 10/15/2025 COVID19
FLU3
 MODERNA
SEQIRUS, INC.

Swelling face; Swelling face Swelling face; Swelling face
Swelling on left size of face Swelling on left size of face
2866174 11 M NY 10/15/2025 FLUN3
FLUN3
 MEDIMMUNE VACCINES, INC.
MEDIMMUNE VACCINES, INC.
 YF3413B
YF3413B
Cough, Headache, Influenza, Malaise, Pyrexia; Respiratory symptom Cough, Headache, Influenza, Malaise, Pyrexia; Respiratory symptom
The patient developed symptoms on 10/12/2025 in the morning - fever, headache, malaise, nasal sympto... The patient developed symptoms on 10/12/2025 in the morning - fever, headache, malaise, nasal symptoms and now a cough. More
2866176 78 M WA 10/15/2025 PNC21
 MERCK & CO. INC.
 Z009681
Dizziness, Vision blurred Dizziness, Vision blurred
Patient experience blurred vision and dizziness the following day. No treatment was needed. Patient experience blurred vision and dizziness the following day. No treatment was needed.
2866177 62 F AZ 10/15/2025 COVID19
COVID19
 MODERNA
MODERNA
 3052731
3052731
Depression, Erythema, Pharyngitis, Pyrexia, Throat irritation; Tongue coated Depression, Erythema, Pharyngitis, Pyrexia, Throat irritation; Tongue coated
Redness spreading down from injection sit eto forearm/elbow, throat irritation/infection, tongue whi... Redness spreading down from injection sit eto forearm/elbow, throat irritation/infection, tongue white/thrush like symptoms along with fever More
2866179 41 F FL 10/15/2025 FLU3
FLU3
 SANOFI PASTEUR
SANOFI PASTEUR
 tfaa2502
tfaa2502
Dizziness, Dysphagia, Dyspnoea, Feeling hot, Flushing; Pharyngeal swelling, Tach... Dizziness, Dysphagia, Dyspnoea, Feeling hot, Flushing; Pharyngeal swelling, Tachycardia, Throat tightness More
The patient came into the pharmacy today and wanted to report that she had a reaction to the vaccine... The patient came into the pharmacy today and wanted to report that she had a reaction to the vaccine on July 29, 2025. 20-30 seconds after the vaccine the patient experienced flushing, tachycardia, difficulty breathing, tightness in the throat with difficulty swallowing or swelling and feeling hot. The pharmacy called 911 and an ambulance arrived within 4-5 minutes. July 30 the patient went to her primary MD (withheld); MD (withheld) confirmed a reaction to the vaccine and sent in a prescription for an EpiPen. Finally she went to an allergist (name withheld); he confirmed her reaction. The patient still complains of tachycardia, SOB and dizziness. More
2866181 3 F MD 10/15/2025 COVID19
 PFIZER\BIONTECH
 na0846
No adverse event, Wrong product administered No adverse event, Wrong product administered
patient got comirnaty instead of spikevax - no symptoms patient got comirnaty instead of spikevax - no symptoms
2866182 4 F MD 10/15/2025 COVID19
 PFIZER\BIONTECH
 na0846
Wrong product administered Wrong product administered
no symptoms - patient got comirnaty instead of spikevax no symptoms - patient got comirnaty instead of spikevax
2866183 71 M ID 10/15/2025 COVID19
FLU3
 PFIZER\BIONTECH
SANOFI PASTEUR
 MY9550
UT8763FA
Injection site pain, Injection site rash; Injection site pain, Injection site ra... Injection site pain, Injection site rash; Injection site pain, Injection site rash More
Patient received the capvaxive vaccine in his right deltoid on monday 10/13. Today on 10/15 patient ... Patient received the capvaxive vaccine in his right deltoid on monday 10/13. Today on 10/15 patient came in due to having a rash a few inches in diameter around the spot of the injection. He also noted that it is still sore. He says he is doing fine and just wanted to report the reaction. More
2866184 61 F MI 10/15/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 7YD42
Burning sensation, Rash, Rash pruritic Burning sensation, Rash, Rash pruritic
patient started getting rash on back of her neck 6-8 hours later after receiving shingles vaccine. i... patient started getting rash on back of her neck 6-8 hours later after receiving shingles vaccine. it was burning and itching at that time. patient started using cortisone cream and it helped a lot. patient called pharmacy on Monday and her symptoms were improved. as per recent conversation on 10/15/25. patients symptoms got significantly improved. it's not burning anymore but still itching little bit. patient took benadryl. she feels it spreaded little bit around the same spot, patient thinks it might be because she was itching. no concern at pt's side at this moment. she will contact us or her dr for if she has any concern More
2866185 60 F VT 10/15/2025 COVID19
FLU3
 MODERNA
SANOFI PASTEUR

No adverse event, Refusal of vaccination; No adverse event, Refusal of vaccinati... No adverse event, Refusal of vaccination; No adverse event, Refusal of vaccination More
Patient was only planning on receiving a flu vaccine while she was at the workplace clinic. There wa... Patient was only planning on receiving a flu vaccine while she was at the workplace clinic. There was a miscommunication and provider thought that she said she was looking for both covid and flu vaccines. Covid vaccine was administered first, then when flu was prepped, the error was discovered. Patient did receive the flu vaccine as planned. Pt did not require treatment and did not have symptoms at administration. An apology was given to the patient and confirmation that she would check in if any adverse events or symptoms occurred in the following few days. More
2866186 76 F VA 10/15/2025 COVID19
FLU3
 MODERNA
SANOFI PASTEUR
 3052296
U8800BA
Injection site pain, Injection site swelling; Injection site pain, Injection sit... Injection site pain, Injection site swelling; Injection site pain, Injection site swelling More
PATIENT GOT THE COVID AND FLU VACCINES ON 09/29/25 AND 2 HOURS AFTER THE INJECTION, THE INJECTION SI... PATIENT GOT THE COVID AND FLU VACCINES ON 09/29/25 AND 2 HOURS AFTER THE INJECTION, THE INJECTION SITE WERE SWOLLEN AND VERY PAINFUL. PATIENT HAS BEEN TRYING HEAT/COLD PATCHES ALONG WITH ALEVE, BUT IT IS STILL DID NOT HELP. More
2866216 82 M GA 10/15/2025 FLU3
 SANOFI PASTEUR
 U8855BA
Injection site bruising Injection site bruising
PATIENT CAME BY THE PHARMACY TO INQUIRE ABOUT HIS ARM, WHICH HAD A PURPLE BRUISE AT THE INJECTION SI... PATIENT CAME BY THE PHARMACY TO INQUIRE ABOUT HIS ARM, WHICH HAD A PURPLE BRUISE AT THE INJECTION SITE OF THE FLU VACCINE. PATIENT STATED THAT THIS STARTED TO OCCUR 2-3 DAYS AFTER RECEIVING VACCINE AND IS NOT TAKING ANY BLOOD THINNERS, AND IS NOT IN ANY PAIN. More
2866217 64 F SC 10/15/2025 FLU3
PNC21
 SANOFI PASTEUR
MERCK & CO. INC.
 u8790aa
z010761
Abdominal pain, Pruritus, Pyrexia, Rash; Abdominal pain, Pruritus, Pyrexia, Rash Abdominal pain, Pruritus, Pyrexia, Rash; Abdominal pain, Pruritus, Pyrexia, Rash
pt said she had abdominal pain, fever, rash on left arm, and a lot of itching-fever and abdominal pa... pt said she had abdominal pain, fever, rash on left arm, and a lot of itching-fever and abdominal pain have gone away but rash, itching is still present More
2866219 16 F ID 10/15/2025 COVID19
FLU3
 PFIZER\BIONTECH
SANOFI PASTEUR
 na0590
tfaa2547
Syncope; Syncope Syncope; Syncope
Fainted within a few minutes of receiving vaccination. She was given water and apple juice and sat... Fainted within a few minutes of receiving vaccination. She was given water and apple juice and sat with her father until she felt better then went home More
2866220 23 F CA 10/15/2025 COVID19
 MODERNA
 3052550
Product preparation error, Underdose Product preparation error, Underdose
patient was administered only half a dose because the remaining part of the dose was frozen. patient was administered only half a dose because the remaining part of the dose was frozen.
2866221 79 F CA 10/15/2025 FLU3
 SANOFI PASTEUR
 UT8763HA
Extra dose administered, No adverse event Extra dose administered, No adverse event
At time of scheduling patent for COVID vaccine asked POA if he wanted flu vaccine at that time must ... At time of scheduling patent for COVID vaccine asked POA if he wanted flu vaccine at that time must have missed understood due to him saying yes, I scheduled pt reviewed PT history and did not see previous dose of HD flu given on 09/23/2025 and scheduled PT for COVID and flu vaccine, at time of administration I introduced myself and explained to PT and caregiver that I will be given two injections 1. COVID and 2. HD FLU provided education on common side effects and what to do in case of adverse effects, after receiving injections I remained with PT for 15-20mins did not observe any adverse signs or symptoms, re-enforced education previously provided thanked PT and care giver for allowing me to come in their home and the opportunity to provide care, on 10/14/2025 after being informed by my management staff I Called son POA for follow up, son states that mother was ok no adverse effects or concerns were noted at time of call, no treatments needed per son . More
2866222 64 M MI 10/15/2025 COVID19
FLU3
 MODERNA
SANOFI PASTEUR
 3052735
U8859CA
Incorrect dose administered, No adverse event; Incorrect dose administered, No a... Incorrect dose administered, No adverse event; Incorrect dose administered, No adverse event More
No Patient adverse event reported. VAERS report is being completed because the patient was not 65 ... No Patient adverse event reported. VAERS report is being completed because the patient was not 65 at time of vaccination with Fluzone High Dose (64yr) More
2866223 45 F AL 10/15/2025 FLU3
 GLAXOSMITHKLINE BIOLOGICALS
 9FG5M
Herpes zoster, Pain, Pyrexia, Rash Herpes zoster, Pain, Pyrexia, Rash
The patient started having a fever and a rash on her body on Saturday, October 2nd. The patient stat... The patient started having a fever and a rash on her body on Saturday, October 2nd. The patient stated she was in a lot of pain. This was 2 days after she received the flu vaccine. Treatment is unknown but she did contact her doctor and the doctor stated she had shingles and it may have been brought on from receiving the flu vaccine. More
2866224 77 F IL 10/15/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 5A4XG
Rash Rash
PATIENT DESCRIBES RASH COVERING RIGHT ARM AFTER VACCINATION PATIENT DESCRIBES RASH COVERING RIGHT ARM AFTER VACCINATION
2866226 60 M FL 10/15/2025 COVID19
 PFIZER\BIONTECH
 NA4457
Extra dose administered Extra dose administered
Patient received 2 of the new covid shots in subsequent months Patient received 2 of the new covid shots in subsequent months
2866228 76 F FL 10/15/2025 RSV
 GLAXOSMITHKLINE BIOLOGICALS
 bg5j4
Extra dose administered Extra dose administered
patient received 2 doses of RSV vaccine over one year apart. this is a once a lifetime vaccine patient received 2 doses of RSV vaccine over one year apart. this is a once a lifetime vaccine
2866229 68 F NC 10/15/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 342xp
Arthralgia, Pain in extremity Arthralgia, Pain in extremity
Patient presented to the pharmacy on 09/23/25 complaining of pain in left shoulder and arm. Patient ... Patient presented to the pharmacy on 09/23/25 complaining of pain in left shoulder and arm. Patient stated had seen/was seeing a doctor for treatment. This was the first notification the pharmacy had received in regards to any adverse events. More
📋 Privacy Policy & Data Disclaimer